Title: Influenza Vaccine: Supply and Distribution
1Influenza VaccineSupply and Distribution
Presented to Evolving Issues in the Prevention
and Treatment of Influenza Media Forum Presented
by Christine M. Layton, PhD, MPH
701 13th St., NW, Suite 750 Washington, DC
20005Phone 410.467.2907 layton_at_rti.org
www.rti.org RTI International is a trade name of
Research Triangle Institute.
2Key Points to be Addressed
- Influenza vaccine supply and distribution is tied
closely to demand - The system by which influenza vaccine is supplied
and distributed is - a. Highly complex
- b. Predominantly a private-sector enterprise
- Means to resolve challenges to influenza vaccine
supply rely on the efforts of multiple
stakeholders
3Demand and Supply
4Influenza Vaccine Doses Produced and Distributed
for the U.S. Market 1999-2004
5Vaccine Supply and Demand are Not in Synch
6Who Orders What From Whom?
7Influenza Vaccine Purchasers Wholesalers
- Wholesalers may be medical-surgical wholesalers
or pharmaceutical wholesalers - Wholesalers often specialize with a particular
type of customer (e.g., cardiologists, large
hospitals, etc.) - The actual number of all wholesalers who offer
influenza vaccine is unknown - Wholesalers may sell to other wholesalers,
so-called redistributors
8Influenza Vaccine Purchasers Immunization
Providers
- Private health care providers
- Private physicians
- Clinics
- Community immunizers
- Visiting Nurse Associations (VNAs)
- Mass immunizers
- State Federal Government
- VFC
- DoD/VA
- Multi-state contracts (e.g., MMCAP)
9US Influenza Vaccine Distribution Pathways
DoD U.S. Department of Defense ERs emergency
rooms LHDs local health departments MMCAP
Minnesota Multi-State Contracting Alliance for
Pharmacy VA U.S. Department of Veterans
Affairs VNAs Visiting Nurse Associations
10Stakeholders Involved in Increasing Demand
- Government (federal, state and local)
- Academia
- Health care providers
- Community immunizers
- Advocacy organizations
- Health insurance companies
- Vaccine industry (manufacturers, distributors)
- Wholesalers
- Professional societies
- Consumers
11Increasing Demand for Influenza Vaccine Increases
Supply of Influenza Vaccine
- Manufacturers produce as much vaccine as they
anticipate they can sell - As past challenges to vaccine supply and
distribution are addressed, all stakeholders need
to work to promote increased uptake of vaccine - Pursue an array of interventions, e.g.
- Increase use by health care workers
- Expand ACIP recommendations
- Broaden immunization season
12The Real Threat
- Mamas little vector
- Childrenespecially young childrenare notorious
for spreading influenza virus